Marija Debeljak, Medical Science Liaison at Bayer, shared a post on LinkedIn:
“New multi-omics integrated review by Anirban Maitra and colleagues highlights the complexity of IPMN biology, from chromatin remodeling and metabolic shifts to microbial influences and immune microenvironment changes.
Integration of genomics, spatial profiling, and functional models is helping identify actionable pathways and potential therapeutic targets in this key pancreatic cancer precursor.”
Title: Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression
Authors: Yuki Makino, Kohki Oyama, Akiko Sagara, Fredrik Ivar Thege, Anirban Maitra
You can read the full article in Springer Nature – Journal of Gastroenterology.
